Molecular biological analysis in a patient with multiple lung adenocarcinomas

Thorac Cancer. 2018 May;9(5):662-665. doi: 10.1111/1759-7714.12634. Epub 2018 Mar 26.

Abstract

The utility of molecular biological analysis in lung adenocarcinoma has been demonstrated. Herein we report a rare case presenting as multiple lung adenocarcinomas with four different EGFR gene mutations detected in three lung tumors. After opacification was detected by routine chest X-ray, the patient, a 64-year-old woman, underwent chest computed tomography which revealed a right lung segment S4 ground-glass nodule (GGN). Follow-up computed tomography revealed a 42 mm GGN nodule with a 26 mm nodule (S6) and a 20 mm GGN (S10). Histopathology of resected specimens from the right middle and lower lobes revealed all three nodules were adenocarcinomas. Four EGFR mutations were detected; no three tumors had the same mutations. Molecular biological analysis is a promising tool for the diagnosis of primary tumors in patients with multiple lung carcinomas of the same histotype, enabling appropriate treatment.

Keywords: Adenocarcinoma of the lung; EGFR mutations; molecular biological analysis; multiple lung cancer.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma of Lung / genetics*
  • Adenocarcinoma of Lung / pathology
  • ErbB Receptors / genetics
  • Female
  • Humans
  • Lung / pathology
  • Middle Aged
  • Mutation
  • Neoplasms, Multiple Primary / genetics*
  • Neoplasms, Multiple Primary / pathology

Substances

  • EGFR protein, human
  • ErbB Receptors